Maintenance fees coming due
14 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Jan 25, 2027. Unpaid by Jul 26, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,708,370 | Solid Forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile In force Fee due Jan 25, 2027 Lapses if unpaid Jul 26, 2027 · High confidence | Principia Biopharma Inc. | In force | Jan 25, 2027 | Jul 26, 2027 | High confidence | |
| US 9,090,621 | Tyrosine Kinase Inhibitors In force Fee due Jan 28, 2027 Lapses if unpaid Jul 28, 2027 · High confidence | Principia Biopharma Inc. | In force | Jan 28, 2027 | Jul 28, 2027 | High confidence | |
| US 10,456,403 | Salts and Solid Form of a BTK Inhibitor In force Fee due Apr 29, 2027 Lapses if unpaid Oct 29, 2027 · High confidence | Principia Biopharma Inc. | In force | Apr 29, 2027 | Oct 29, 2027 | High confidence | |
| US 11,814,390 | Crystalline Forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile In force Fee due May 14, 2027 Lapses if unpaid Nov 15, 2027 · High confidence | Principia Biopharma Inc. | In force | May 14, 2027 | Nov 15, 2027 | High confidence | |
| US 9,187,487 | Azaindole Derivatives as Tyrosine Kinase Inhibitors In force Fee due May 17, 2027 Lapses if unpaid Nov 17, 2027 · High confidence | Principia Biopharma, Inc. | In force | May 17, 2027 | Nov 17, 2027 | High confidence | |
| US 10,485,797 | Treatment of Pemphigus In force Fee due May 26, 2027 Lapses if unpaid Nov 26, 2027 · High confidence | Principia Biopharma Inc. | In force | May 26, 2027 | Nov 26, 2027 | High confidence | |
| US 11,827,656 | Immunoproteasome Inhibitors In force Fee due May 28, 2027 Lapses if unpaid Nov 29, 2027 · High confidence | Principia Biopharma Inc. | In force | May 28, 2027 | Nov 29, 2027 | High confidence | |
| US 10,533,013 | SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORS In force Fee due Jul 14, 2027 Lapses if unpaid Jan 14, 2028 · High confidence | Principia Biopharma Inc. | In force | Jul 14, 2027 | Jan 14, 2028 | High confidence | |
| US 11,872,229 | Modified Release Formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile In force Fee due Jul 16, 2027 Lapses if unpaid Jan 18, 2028 · High confidence | Principia Biopharma Inc. | In force | Jul 16, 2027 | Jan 18, 2028 | High confidence | |
| US 10,538,517 | Quinolone Derivatives as FGFR Inhibitors In force Fee due Jul 21, 2027 Lapses if unpaid Jan 21, 2028 · High confidence | Principia Biopharma, Inc. | In force | Jul 21, 2027 | Jan 21, 2028 | High confidence | |
| 4 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro | |||||||
10 of 14 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.